Year: 2023

Free-to-attend industry-wide safety event promotes lifelong learning opportunities highlighting the latest safety knowledge available throughout the industry Wichita-based event set to bring over 400 aviation professionals together in person, and more than 1,000 more via webcast Essential free aviation training opportunities focus on fatigue risk management, integrity in the cockpit, expanding crew emergency response training, building a culture of excellence and much moreMONTRÉAL, Nov. 06, 2023 (GLOBE NEWSWIRE) — Bombardier’s industry-leading Safety Standdown, a ‘must-attend’ safety conference promoting invaluable lifelong learning opportunities, is set to run November 7-9 at the Hyatt Regency Hotel in Wichita, KS. The 27th edition of this comprehensive three-day conference features unique learning opportunities, dynamic workshops...

MINNEAPOLIS, Nov. 06, 2023 (GLOBE NEWSWIRE) — Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the third quarter 2023 before the market opens on Monday, November 13, 2023. Management will host a webcast/teleconference the same day at 8:00 a.m. Eastern Time to discuss the results and provide a corporate update. Webcast and Conference Call Information   To participate in the teleconference, domestic callers should dial 1-877-407-0784 or1-201-689-8560. A live webcast presentation can also be accessed using this weblink: https://viavid.webcasts.com/starthere.jsp?ei=1639042&tp_key=7d2827005c. A replay of the webcast will be available on the Celcuity website following the live event.   About...

MIAMI, Nov. 06, 2023 (GLOBE NEWSWIRE) — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator (“MSO”), announced the opening of two Ohio retail locations in Woodmere and Goshen. The Woodmere store opens today and the Goshen store is expected to open later this week. “Ohio is one of the most promising cannabis markets in the country, with a growing medical program and adult-use legalization to appear on this week’s ballot referendum,” said David Goubert, President and CEO of AYR. “Via our support relationship with Twice the Wellness in Woodmere and Heaven Wellness in Goshen, we look forward to building a great relationship with customers and both local communities.” AYR has the future rights to ownership of both dispensaries, subject to regulatory...

Not for distribution to United States Newswire Services or for dissemination in the United States VANCOUVER, British Columbia, Nov. 06, 2023 (GLOBE NEWSWIRE) — Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton”) is pleased to announce that, due to overwhelming interest, the Company’s non-brokered private placement previously announced on October 30, 2023 (the “Offering“) has been over-subscribed. The Offering will now consist of up to 12,100,000 units (“Units”), up to 49,652,994 national flow-through units (“NFT Units”) and up to 15,726,216 charity flow-through units (“Charity FT Units”), for total gross proceeds of up to $14,030,300. All other terms of the Offering remain unchanged. Subject to compliance with applicable regulatory requirements and in accordance with National Instrument...

Expect to initiate Phase 1 development in mid-2024 to compare pharmacokinetics of subcutaneous form to intravenous form of ACU193 CHARLOTTESVILLE, VA. and INDIANAPOLIS, IN., Nov. 06, 2023 (GLOBE NEWSWIRE) —  Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), today announced a global non-exclusive collaboration and license agreement with Halozyme Therapeutics Inc. (“Halozyme”). The collaboration will provide Acumen access to Halozyme’s ENHANZE® drug delivery technology, based on a recombinant human hyaluronidase PH20 enzyme (rHuPH20), for the development of a subcutaneous formulation of ACU193, the first clinical-stage AβO-targeting...

HOUSTON, TX, Nov. 06, 2023 (GLOBE NEWSWIRE) — Prairie Operating Co. (OTCQB: CRKRD; the “Company” or “Prairie”) is pleased to announce that Richard N. Frommer, former Great Western Petroleum Chief Executive Officer and energy industry veteran, has joined its Advisory Board.  Mr. Frommer brings over four (4) decades of oil and gas industry experience to Prairie’s Advisory Board, having led and collaborated with board of directors and management teams across various regions, spanning from Canada to the Gulf Coast. Throughout his career, Mr. Frommer has demonstrated a successful track record of building and monetizing multiple billion-dollar oil and gas companies.  In addition, as the Chairman of the Trade Association for the Colorado Oil and Gas Association, Mr. Frommer was instrumental in shaping the regulatory framework for oil...

Multi-national, randomized, controlled adaptive Phase III study in ulcerative pyoderma gangrenosum (PG) initiated and first patient dosed in the U.S. PG is a rare and debilitating autoimmune skin disease characterized by painful ulcers that can rapidly progressJENA, Germany, Nov. 06, 2023 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a biotechnology company pioneering anti-inflammatory therapeutics targeting the complement system, announced today that the first patient has been dosed in its Phase III study investigating the efficacy and safety of vilobelimab in ulcerative PG, a rare neutrophilic and inflammatory skin disease characterized by destructive, painful cutaneous ulcers. “We are pleased that the first patient has been dosed in the U.S. in our pivotal Phase III study with vilobelimab for the treatment of ulcerative...